Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03361228
Title A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Incyte Corporation

lung non-small cell carcinoma


colorectal cancer

Advanced Solid Tumor

transitional cell carcinoma

head and neck squamous cell carcinoma

lung small cell carcinoma


Epacadostat + INCB001158

Epacadostat + INCB001158 + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.